Research reference only — not a catalog item
Thymogen
Research context
A long-term rat study recorded survival and spontaneous tumor counts after repeated subcutaneous administration of the dipeptide Thymogen (L-Glu-L-Trp) to outbred female rats.
What has been studied
- Rat cohort
Anisimov, Khavinson, and Morozov (2000) gave the dipeptide L-Glu-L-Trp by repeated subcutaneous injection to outbred female rats and followed the cohort to natural death. The recorded endpoints were survival and microscopically examined spontaneous tumors.
These labels restate the setting of the cited paper. They are not new findings and do not describe a catalog material.
Research model areas
- Female rat survival counts
- Spontaneous tumor counts
Selected published literature
What remains uncertain
Limitations
Survival and tumor-count endpoints in one rat cohort do not establish a human immune, aging, or cancer outcome.
Model areas in the Body Explorer: Immune signaling models.